Fact CheckerSign in

NCT07833930Recruiting

Incidence and Clinical Features of Breakthrough Pain After Brachial Plexus Block in Diabetic Patients

An Observational Study on Incidence and Clinical Characteristics of Breakthrough Pain Following Brachial Plexus Block in Adult Patients With Diabetes Mellitus

Source: ClinicalTrials.gov · Last updated 22 Sept 2026

Brief summary (registry, in English)

This observational study aims to determine the incidence and clinical characteristics of rebound-breakthrough pain after ultrasound-guided brachial plexus block in adult patients with type 2 diabetes mellitus. Adult patients undergoing elective upper-extremity surgery are divided into a type 2 diabetes group and a non-diabetic control group. Baseline clinical data and pain-related outcomes are collected after nerve block. This work may provide evidence for optimizing perioperative pain management for diabetic patients receiving brachial plexus block.

Status (registry)
Recruiting
Study type
Observational
Enrollment
216 (estimated)
First submitted
12 Sept 2026
Start date
20 Sept 2025
Primary completion date
20 Sept 2026
Lead sponsor
Second Hospital of Shanxi Medical University
NCT number
NCT07833930

What you commit to

  • Study type: Observational
  • Planned participants: 216
  • From 20 Sept 2025 to the primary completion date, 20 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Chronic regular use of opioids before surgery

Other illness

  • Allergy or contraindication to amide-type local anesthetics
  • Coagulopathy or infection at the block puncture site

Other

  • Pre-existing peripheral neuropathy of the affected upper limb
  • Cognitive dysfunction unable to complete NRS pain evaluation
  • Pregnancy or lactation
  • Incomplete clinical data expected during follow-up

Who the study is looking for

  • Aged 18 years or older
  • Undergoing elective upper-extremity surgery
  • Planned for ultrasound-guided brachial plexus block with 0.375% ropivacaine
  • Able to cooperate with pain assessment and follow-up within 48 hours after block
  • Written informed consent obtained

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Second hospital of Shanxi Medical University
Coordinator of this site? Confirm its status
TaiyuanChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.